"AIDS Antigen Test" CDC Daily UpdateImportant note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow



"AIDS Antigen Test"

JAMA (12/15/89) Vol. 262, No. 23, P. 3254


Abstract: FDA has approved a new diagnostic kit to detect the presence of the human immunodeficiency virus type 1 (HIV-1) in serum and plasma. HIVAG-1 and HIVAG-1 Blocking Antibody, from Abbott Laboratories, differs from other enzyme-linked immunoassaytest, particle agglutination tests, or Western blot tests becauseit detects viral antigen rather than antibodies formed by the immune system in response to the HIV-1 antigen. Since HIV-1 antibodies can take an average of 3 to 6 months to develop, the antigen test may detect the presence of the virus earlier than existing antibody tests, making it an extremely useful diagnostictest. In comparison with antibody testing though, antigen testing will only detect about 50 percent of AIDS, 30 percent of AIDS-related complex, and 10 percent of asymptomatic HIV-1 infections, and it should not be used in lieu of antibody testingas a screen for HIV-1 infection.


891215
AD892733


Copyright © 1989 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.